Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
acute, ampule, autoinjector, baseline, Biden, Carbaglu, Carglumic, CGT, chronic, combat, Crossject, deficiency, DJB, driven, eleven, Emerphed, endocrinology, eprontia, extinguishment, forgiven, HCl, hyperammonemia, ID, kit, lab, lyophilized, NaN, nominal, Novitium, outsource, reconstituted, rescue, retired, retirement, salesforce, Speech, Synthase, Tolmar, twenty, underwritten, vial, XGen, zeneo
Removed:
affiliate, antidilutive, ASU, Bulletin, cancel, comparative, compounded, compute, consultant, conversion, divisor, eliminated, entitle, fixed, forfeited, initiation, instrument, levothyroxine, liquidation, manually, Oakwood, pipeline, proven, provisional, ratably, reclassified, recoup, redeemable, redemption, remained, Road, SAB, sterility, territorial, unpaid
Filing tables
Filing exhibits
Related press release
Associated ETON transcripts
ETON similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in Registration Statement Nos. 333-228493 and 333-230572 on Form S-8 and Registration Statement Nos. 333-235329 and 333-240252 on Form S-3 of our report dated March 16, 2022, relating to the financial statements of Eton Pharmaceuticals, Inc., appearing in this Annual Report on Form 10-K of Eton Pharmaceuticals, Inc. for the year ended December 31, 2021.
/s/ KMJ Corbin & Company LLP
Irvine, California
March 16, 2022